Selected research
Industry Research
Antibody Fragments Industry Research Report 2026
Market perspective
The global Antibody Fragments market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antibody Fragments is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antibody Fragments is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antibody Fragments is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antibody Fragments include AbbVie, Amgen, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Eli Lilly, Novartis, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antibody Fragments market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antibody Fragments Market by Company
AbbVie
Amgen
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Eli Lilly
Novartis
Johnson & Johnson
Sanofi
Takeda Pharmaceutical
Antibody Fragments Segment by Type
F(ab) Fragment
F(ab’)2 Fragment
Antibody Fragments Segment by Application
Cancer
Immunodeficiencies
Other
Antibody Fragments Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Fragments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Fragments and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Fragments.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antibody Fragments manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antibody Fragments by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antibody Fragments in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- F(ab) Fragment
- F(ab’)2 Fragment
Applications
- Cancer
- Immunodeficiencies
- Other
Companies covered
- AbbVie
- Amgen
- Biogen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Eli Lilly
- Novartis
- Johnson & Johnson
- Sanofi
- Takeda Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antibody Fragments Market Size (2021-2032)
- 2.2.2 Global Antibody Fragments Sales (2021-2032)
- 2.2.3 Global Antibody Fragments Market Average Price (2021-2032)
- 2.3 Antibody Fragments by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 F(ab) Fragment
- 2.3.3 F(ab’)2 Fragment
- 2.4 Antibody Fragments by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer
- 2.4.3 Immunodeficiencies
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antibody Fragments Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antibody Fragments Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Antibody Fragments Revenue of Manufacturers (2021-2026)
- 3.4 Global Antibody Fragments Average Price by Manufacturers (2021-2026)
- 3.5 Global Antibody Fragments Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antibody Fragments, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antibody Fragments, Product Type & Application
- 3.8 Global Manufacturers of Antibody Fragments, Established Date
- 3.9 Global Antibody Fragments Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AbbVie
- 4.1.1 AbbVie Company Information
- 4.1.2 AbbVie Business Overview
- 4.1.3 AbbVie Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AbbVie Antibody Fragments Product Portfolio
- 4.1.5 AbbVie Recent Developments
- 4.2 Amgen
- 4.2.1 Amgen Company Information
- 4.2.2 Amgen Business Overview
- 4.2.3 Amgen Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amgen Antibody Fragments Product Portfolio
- 4.2.5 Amgen Recent Developments
- 4.3 Biogen
- 4.3.1 Biogen Company Information
- 4.3.2 Biogen Business Overview
- 4.3.3 Biogen Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biogen Antibody Fragments Product Portfolio
- 4.3.5 Biogen Recent Developments
- 4.4 Bristol-Myers Squibb
- 4.4.1 Bristol-Myers Squibb Company Information
- 4.4.2 Bristol-Myers Squibb Business Overview
- 4.4.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bristol-Myers Squibb Antibody Fragments Product Portfolio
- 4.4.5 Bristol-Myers Squibb Recent Developments
- 4.5 F. Hoffmann-La Roche
- 4.5.1 F. Hoffmann-La Roche Company Information
- 4.5.2 F. Hoffmann-La Roche Business Overview
- 4.5.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 F. Hoffmann-La Roche Antibody Fragments Product Portfolio
- 4.5.5 F. Hoffmann-La Roche Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Company Information
- 4.6.2 Eli Lilly Business Overview
- 4.6.3 Eli Lilly Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Antibody Fragments Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Company Information
- 4.7.2 Novartis Business Overview
- 4.7.3 Novartis Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis Antibody Fragments Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Company Information
- 4.8.2 Johnson & Johnson Business Overview
- 4.8.3 Johnson & Johnson Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Antibody Fragments Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 Sanofi
- 4.9.1 Sanofi Company Information
- 4.9.2 Sanofi Business Overview
- 4.9.3 Sanofi Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sanofi Antibody Fragments Product Portfolio
- 4.9.5 Sanofi Recent Developments
- 4.10 Takeda Pharmaceutical
- 4.10.1 Takeda Pharmaceutical Company Information
- 4.10.2 Takeda Pharmaceutical Business Overview
- 4.10.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Takeda Pharmaceutical Antibody Fragments Product Portfolio
- 4.10.5 Takeda Pharmaceutical Recent Developments
5 Global Antibody Fragments Market Scenario by Region
- 5.1 Global Antibody Fragments Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antibody Fragments Sales by Region: 2021-2032
- 5.2.1 Global Antibody Fragments Sales by Region: 2021-2026
- 5.2.2 Global Antibody Fragments Sales by Region: 2027-2032
- 5.3 Global Antibody Fragments Revenue by Region: 2021-2032
- 5.3.1 Global Antibody Fragments Revenue by Region: 2021-2026
- 5.3.2 Global Antibody Fragments Revenue by Region: 2027-2032
- 5.4 North America Antibody Fragments Market Facts & Figures by Country
- 5.4.1 North America Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antibody Fragments Sales by Country (2021-2032)
- 5.4.3 North America Antibody Fragments Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Antibody Fragments Market Facts & Figures by Country
- 5.5.1 Europe Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antibody Fragments Sales by Country (2021-2032)
- 5.5.3 Europe Antibody Fragments Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Antibody Fragments Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antibody Fragments Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antibody Fragments Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antibody Fragments Market Facts & Figures by Country
- 5.7.1 South America Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antibody Fragments Sales by Country (2021-2032)
- 5.7.3 South America Antibody Fragments Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Antibody Fragments Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antibody Fragments Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antibody Fragments Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Antibody Fragments Sales by Type (2021-2032)
- 6.1.1 Global Antibody Fragments Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Antibody Fragments Sales Market Share by Type (2021-2032)
- 6.2 Global Antibody Fragments Revenue by Type (2021-2032)
- 6.2.1 Global Antibody Fragments Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antibody Fragments Revenue Market Share by Type (2021-2032)
- 6.3 Global Antibody Fragments Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antibody Fragments Sales by Application (2021-2032)
- 7.1.1 Global Antibody Fragments Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Antibody Fragments Sales Market Share by Application (2021-2032)
- 7.2 Global Antibody Fragments Revenue by Application (2021-2032)
- 7.2.1 Global Antibody Fragments Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antibody Fragments Revenue Market Share by Application (2021-2032)
- 7.3 Global Antibody Fragments Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antibody Fragments Value Chain Analysis
- 8.1.1 Antibody Fragments Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antibody Fragments Production Mode & Process
- 8.2 Antibody Fragments Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antibody Fragments Distributors
- 8.2.3 Antibody Fragments Customers
9 Global Antibody Fragments Analyzing Market Dynamics
- 9.1 Antibody Fragments Industry Trends
- 9.2 Antibody Fragments Industry Drivers
- 9.3 Antibody Fragments Industry Opportunities and Challenges
- 9.4 Antibody Fragments Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst